Alterations in TERT are implicated in the aggressiveness of thyroid cancer and are associated with worse patient outcomes, especially when they co-occur with alterations in BRAF or RAS genes (12, 65, 67, 68, 69). The gene discussed is TERT; the disease is thyroid gland carcinoma.